Elastomers for Pharmaceuticals: Introduction

  • Elastomer is defined as a long chain co-polymer or terpolymer (two or three different monomers in one chain) that contains adequate crosslinks among individual chains. Elastomers are polymers that offer excellent properties such as high elasticity as well as viscosity. They offer low permeability to moisture and gas; as well as high temperature resistance. Fluorinated elastomers are more stable than hydrocarbon or silicon elastomers, as C-F bonds are approximately 30% stronger than C-H bonds.
  • Elastomers help meet the changing requirements of drug compatibility and cleanliness in pharmaceutical, medical and health care industries. They offer several beneficial properties. For instance, they possess low extractability and leachability. Elastomers are super-clean solutions for sensitive drugs and various other pharmaceutical applications such as pharmaceutical stoppers and container closures.
  • Products manufactured from specialty polymer materials need to be non-toxic and suitable for selected medical devices. They need to be tested and certified to according to the United States Pharmacopeia (USP) Class VI. Five major FDA compliant elastomers are used in pharmaceutical and biopharmaceutical industries: EPDM (ethylene-propylene-diene rubber), fluoroelastomers (FKM), platinum-cured silicon (pt-Si), and finally Kalrez parts using compounds KLR-6221 and KLR-6230, which are perfluoroelastomers.

Key Drivers and Restraints of Global Elastomers for Pharmaceuticals Market

  • Rise in complexity of new pharmacological interventions has prompted companies to manufacture compatible container closures with the use of versatile materials. This is driving the demand for elastomers for pharmaceuticals.
  • The pharmaceutical industry has been expanding in developing economies such as China, India, and Brazil due to rise in disposable income of the people, increase in population, and growth in focus on health care. This is estimated to drive the market in the near future.
  • Demographic trends such as increase in population, including old age population, are likely to drive the demand for pharmaceutical products during the forecast period. This, in turn, is projected to fuel the demand for elastomers for the pharmaceuticals market.
  • High cost involved in processing of pharmaceutical elastomers is a major factor hampering the market. Volatility in prices of raw materials due to lack of availability of proper resources is also adversely affecting the market.

Elastomers for Pharmaceuticals: Application Segment

  • In terms of application, the global elastomers for pharmaceuticals market can be segmented into oil & gas, building & construction, paints & coatings, pharmaceutical, chemical, and others

Covid-19 Impact on Elastomers for Pharmaceuticals Market

  • Several governments and private sector businesses are operating on a limited capacity or have ceased operations completely due to recent events surrounding the COVID-19 pandemic. Various manufacturing activities of different materials and products across the globe came to a halt due to the unavailability of raw materials and shortage of labor.
  • The elastomer for pharmaceuticals market has been facing supply-demand shortages due to the industrial shutdown triggered by the COVID 19 outbreak. Supply shortage has also resulted in an increase in prices of raw materials. Affected downstream supply chain might take longer to recover. The industrial shutdown has adversely impacted product and inventory transportation, as logistic services have been hampered due to the COVID-19 outbreak. These factors are expected to adversely affect the elastomer for pharmaceuticals market in the near future.

Asia Pacific to Dominate Elastomers for Pharmaceuticals Market

  • In terms of region, the global elastomers for pharmaceuticals market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • Asia Pacific dominated the global market in 2019, due to the presence of key manufacturers across the region. India, China, Thailand, Singapore, and Malaysia offer lucrative opportunities for the market owing to increase in population, improvement in standard of living, growth in economic development, and increase in expenditure on health care. Expansion of the pharmaceuticals industry in Asia Pacific is likely to boost the elastomer for pharmaceuticals market in the region in the near future.
  • North America is also likely to hold key share of the global elastomer for pharmaceuticals market during the forecast period. Europe holds important position in the market. The market in Germany in Europe is anticipated to expand at a faster pace during the forecast period.

Key Manufacturers Operating in Global Elastomers for Pharmaceuticals Market

The global elastomers for pharmaceuticals market was highly fragmented in 2019. Major players have prominent presence in developed and developing countries. Key manufacturers operating in the global elastomers for pharmaceuticals market include:

  • Exxon Mobil Corporation
  • James Walker
  • Eastman Chemical Company
  • ERIKS
  • DuPont
  • West Pharmaceutical Services, Inc.
  • Trelleborg Healthcare & Medical
  • Precision Polymer Engineering/IDEX

Global Elastomers for Pharmaceuticals Market: Research Scope

Global Elastomers for Pharmaceuticals Market, by Type

  • Thermoset Elastomers
    • Silicone
    • Others
  • Thermoplastic Elastomers
  • Thermoplastic Polyurethane
  • Styrene Block Copolymers
  • Others

Global Elastomers for Pharmaceuticals Market, by Application

  • Stoppers
  • Cartridges
  • Syringes
  • Needle Shields
  • Others

Disclaimer: This ongoing market research study is a meticulously planned activity where a broad array of factors and aspects that shape the marketing environment and industry are taken into account. However, keeping in mind the constantly changing nature of business dynamics and changing strategic intents, we are always actively making iterations and modifications in our approaches. As always, we are ready to tailor our insights and guidance to suit your requirements. Engage with us to know what more is there for your CXOs.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Elastomers For Pharmaceuticals Market